Loading…
Reported covered position: Rep. Perlmutter; Chieff of Staff to Rep. McCarthy
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Pharmacy and Medically Underserved Areas Enhancement Act
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs/MAC pricing Biosimiliars Drug importation Generics labeling Pharmacy Benefit Managers Preferred pharmacy network - HR793 Electronic labeling 21st century cures - HR6 Drug Disposal/Management Drug Prices
Pharmacy and Medically Underserved Areas Enhancement Act
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2016 · second_quarter · Q2
Prescription drug monitoring programs Prescription drug abuse/substance use disorder
Chronic Conditions Medicare Part D Medicare Part B Medication Therapy Management Waste, fraud and abuse HIT/EHR Prescription drug abuse
Source: Senate LDA
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs/MAC pricing Biosimiliars Drug importation Generics labeling Pharmacy Benefit Managers Preferred pharmacy network - HR793 Electronic labeling 21st century cures - HR6 Drug Disposal/Management Drug Prices
21st Century Cures Act
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs/MAC pricing Biosimiliars Drug importation Generics labeling Pharmacy Benefit Managers Preferred pharmacy network - HR793 Electronic labeling 21st century cures - HR6 Drug Disposal/Management Drug Prices
21st Century Cures Act
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs/MAC pricing Biosimiliars Drug importation Generics labeling Pharmacy Benefit Managers Preferred pharmacy network - HR793 Electronic labeling 21st century cures - HR6 Drug Disposal/Management Drug Prices
Ensuring Seniors Access to Local Pharmacies Act of 2015
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs/MAC pricing Biosimiliars Drug importation Generics labeling Pharmacy Benefit Managers Preferred pharmacy network - HR793 Electronic labeling 21st century cures - HR6 Drug Disposal/Management Drug Prices
Ensuring Seniors Access to Local Pharmacies Act of 2015
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs/MAC pricing Biosimiliars Drug importation Generics labeling Pharmacy Benefit Managers Preferred pharmacy network - HR793 Electronic labeling 21st century cures - HR6 Drug Disposal/Management Drug Prices
Pharmacy and Medically Underserved Areas Enhancement Act
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs/MAC pricing Biosimiliars Drug importation Generics labeling Pharmacy Benefit Managers Preferred pharmacy network - HR793 Electronic labeling 21st century cures - HR6 Drug Disposal/Management Drug Prices
Pharmacy and Medically Underserved Areas Enhancement Act
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs/MAC pricing Biosimiliars Drug importation Generics labeling Pharmacy Benefit Managers Preferred pharmacy network - HR793 Electronic labeling 21st century cures - HR6 Drug Disposal/Management Drug Prices
Medicare Access and CHIP Reauthorization Act of 2015
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Medicare Part D Medicare Part B Medication Therapy Management Waste, fraud and abuse SGR - HR2 Preferred cost sharing
MAC Transparency Act
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures Precision medicine/pharmacogenomics Maximum allowable cost - HR244
Pharmacy and Medically Underserved Areas Enhancement Act
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures Drug Disposal
Pharmacy and Medically Underserved Areas Enhancement Act
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures
Pharmacy and Medically Underserved Areas Enhancement Act
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures Precision medicine/pharmacogenomics Maximum allowable cost - HR244
Pharmacy and Medically Underserved Areas Enhancement Act
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs/MAC pricing Biosimiliars Drug importation Generics labeling Pharmacy Benefit Managers Preferred pharmacy network - HR793 Electronic labeling 21st century cures - HR6 Drug Disposal Drug Prices
21st Century Cures Act
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs/MAC pricing Biosimiliars Drug importation Generics labeling Pharmacy Benefit Managers Preferred pharmacy network - HR793 Electronic labeling 21st century cures - HR6 Drug Disposal Drug Prices
Medicare Home Infusion Site of Care Act of 2015
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures
Medicare Home Infusion Site of Care Act of 2015
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures Precision medicine/pharmacogenomics Maximum allowable cost - HR244
Medicare Home Infusion Site of Care Act of 2015
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures Drug Disposal
Ensuring Seniors Access to Local Pharmacies Act of 2015
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures Drug Disposal
Ensuring Seniors Access to Local Pharmacies Act of 2015
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs/MAC pricing Biosimiliars Drug importation Generics labeling Pharmacy Benefit Managers Preferred pharmacy network - HR793 Electronic labeling 21st century cures - HR6 Drug Disposal Drug Prices
Ensuring Seniors Access to Local Pharmacies Act of 2015
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures
Ensuring Seniors Access to Local Pharmacies Act of 2015
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures Precision medicine/pharmacogenomics Maximum allowable cost - HR244
Medicare Home Infusion Site of Care Act of 2015
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures
Medicare Home Infusion Site of Care Act of 2015
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures Precision medicine/pharmacogenomics Maximum allowable cost - HR244
Medicare Home Infusion Site of Care Act of 2015
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures Drug Disposal
Pharmacy and Medically Underserved Areas Enhancement Act
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures Drug Disposal
Pharmacy and Medically Underserved Areas Enhancement Act
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures Precision medicine/pharmacogenomics Maximum allowable cost - HR244
Pharmacy and Medically Underserved Areas Enhancement Act
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs/MAC pricing Biosimiliars Drug importation Generics labeling Pharmacy Benefit Managers Preferred pharmacy network - HR793 Electronic labeling 21st century cures - HR6 Drug Disposal Drug Prices
Pharmacy and Medically Underserved Areas Enhancement Act
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures
To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
Reimbursement for pharmacists services - HR 4190 Transitions of care Risk evaluation and mitigation services Track and Trace/supply chain Health Information Technology Immunization Drug Quality and Security Act (PL 113-54) Compounding FDASIA (PL 112-144) Tele-medicine Quality rating AMP FUL's Biosimiliars Drug importation Generics labeling
Medication Therapy Management Benefits Act of 2011
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
S. 274 Medication Therapy Management Empowerment Act of 2011. H.R. 891 Medication Therapy Management Benefits Act of 2011. Agency issues related to standardized medication action plans; accountable care organizations (ACOs); pharmacists' participation in CMS Innovation Center initiatives; coverage for outpatient drugs; transparency and reporting of physician investment interests (Sunshine Act); potential new paradigm for drugs; essential health benefits (EHB); and standardized pharmacy notice.
Medication Therapy Management Benefits Act of 2011
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
S. 2.74 Medication Therapy Management Empowerment Act of 2011. H.R. 891 Medication Therapy management Benefits Act of 2011. Agency issues related to standardized medication action plans; accountable care organizations; pharmacists' participation in the CMS Innovation Center initiatives; personalized medication lists; essential health benefits; and standardized pharmacy notice.
Medication Therapy Management Benefits Act of 2011
Client: AMERICAN PHARMACISTS ASSOCIATION · Firm: AMERICAN PHARMACISTS ASSOCIATION
S.274 Medication Therapy Management Empowerment Act of 2011 H.R.891 Medication Therapy Management Benefits Act of 2011 Agency issues related to standardized medication action plans; accountable care organizations; pharmacists' participation in the CMS Innovation Center initiatives; personalized medication lists; standardized pharmacy notice. immunization; and health information technology. Communications with the Joint Select Committee on Deficit Reduction on preserving patient access to medication therapy management services in Medicare Part D, fair reimbursement in Medicare and Medicaid.
HCR (PL 111-152/111-148) Coordination of care ACOs - PCMHs
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs/MAC pricing Biosimiliars Drug importation Generics labeling Pharmacy Benefit Managers Preferred pharmacy network - HR793 Electronic labeling 21st century cures - HR6 Drug Disposal/Management Drug Prices
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2016 · first_quarter · Q1
HCR (PL 111-152/111-148) Coordination of care ACOs - PCMHs
Prescription drug monitoring programs Prescription drug abuse/substance use disorder
Chronic Conditions Medicare Part D Medicare Part B Medication Therapy Management Waste, fraud and abuse HIT/EHR
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs/MAC pricing Biosimiliars Drug importation Generics labeling Pharmacy Benefit Managers Preferred pharmacy network - HR793 Electronic labeling 21st century cures - HR6 Drug Disposal/Management Drug Prices
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2015 · fourth_quarter · Q4
Chronic Conditions Medicare Part D Medicare Part B Medication Therapy Management Waste, fraud and abuse
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs/MAC pricing Biosimiliars Drug importation Generics labeling Pharmacy Benefit Managers Preferred pharmacy network - HR793 Electronic labeling 21st century cures - HR6 Drug Disposal Drug Prices
HCR (PL 111-152/111-148) Coordination of care ACOs - PCMHs
Prescription drug monitoring programs Prescription drug abuse
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2015 · third_quarter · Q3
HCR (PL 111-152/111-148) Coordination of care Integrated care Social security act ACOs - PCMHs
Prescription drug monitoring programs Prescription drug abuse
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures Drug Disposal
Medicare Part D Medicare Part B Medication Therapy Management Waste, fraud and abuse
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2015 · second_quarter · Q2
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures
HCR (PL 111-152/111-148) Coordination of care Integrated care Social security act ACOs - PCMHs
Medicare Part D Medicare Part B Medication Therapy Management Waste, fraud and abuse
Prescription drug monitoring programs Prescription drug abuse Prescription drug disposal
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2015 · first_quarter · Q1
Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures Precision medicine/pharmacogenomics Maximum allowable cost - HR244
HCR (PL 111-152/111-148) Coordination of care Integrated care Social security act ACOs
Medicare Part D Medicare Part B Medication Therapy Management Waste, fraud and abuse SGR - HR2 Preferred cost sharing
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2014 · fourth_quarter · Q4
HCR (PL 111-152/111-148) Coordination of care Integrated Care Social Security Act Accountable Care Organizations
Prescription drug monitoring programs Prescription drug abuse Hydrocodone
Reimbursement for pharmacists services - HR 4190 Transitions of care Risk evaluation and mitigation services Track and Trace/supply chain Health Information Technology Immunization Drug Quality and Security Act (PL 113-54) Compounding FDASIA (PL 112-144) Tele-medicine Quality rating AMP FUL's Biosimiliars Drug importation Generics labeling
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2014 · third_quarter · Q3
HCR(PL 111-152/111-148); Medicare Part D; MTM; Medicare Part B; reimbursement for pharmacist services; Social Security Act; transitions of care; risk evaluation and mitigation services; PDMP; prescription drug abuse; hydrocodone; track and trace/supply chain; ACOs; immunization; HIT; compounding; SGR; FDASIA(PL 112-144); tele-medicine; Medicare fraud, waste and abuse; quality rating; AMP FUL's; biosimilars; drug importation; generics labeling; coordination of care; integrated care; value-based payments
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2014 · second_quarter · Q2
HCR(PL 111-152/111-148); Medicare Part D; Medication Therapy Management; Medicare Part B; reimbursement for pharmacist services; Social Security Act; transitions of care; risk evaluation and mitigation services; prescription drug monitoring program; prescription drug abuse; hydrocodone; track and trace/supply chain; ACOs; immunization; HIT; compounding; Sustainable Growth Rate; FDASIA(PL 112-144); tele-medicine; Medicare fraud, waste and abuse; quality rating; AMP FUL's
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2014 · first_quarter · Q1
HCR(PL 111-152/111-148); Medicare Part D; Medication Therapy Management; Medicare Part B; reimbursement for pharmacist services; Social Security Act; transitions of care; risk evaluation and mitigation services; prescription drug monitoring program; prescription drug abuse; hydrocodone; track and trace/supply chain; ACOs; immunization; HIT; compounding; Sustainable Growth Rate; FDASIA(PL 112-144); tele-medicine; Medicare fraud, waste and abuse; quality rating; AMP FUL's
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2013 · first_quarter · 1A
HCR(PL 111-152/111-148) concerning Medicare PartD;MTM;DME;center for medicare and medicaid innovation;transitions of care;pharmacy reibursement;agency issues concerning risk evaluation mitigation strategies;PDUFA;prescription drug monitoring program,drug abuse,safe drug supply chain;standardized medication action plans;ACOs;pharmacists role in CMS innovation center initiatives;personalized medication lists; standardized pharmacy notice;immunization;HIT; compounding; medicare Part B; SGR; DEA
Filing targets: Centers For Disease Control & Prevention (CDC), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2013 · fourth_quarter · Q4
HCR(PL 111-152/111-148); Medicare Part D; Medication Therapy Management; Medicare Part B; reimbursement for pharmacist services; Social Security Act; DME; CMMI; transitions of care; risk evaluation and mitigation services; prescription drug monitoring program; prescription drug abuse; hydrocodone; track and trace/supply chain; ACOs; immunization; HIT; compounding; Sustainable Growth Rate; FDASIA(PL 112-144); tele-medicine; Medicare fraud, waste and abuse; quality rating; standardized pharmacy notice
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2013 · third_quarter · Q3
HCR(PL 111-152/111-148); Medicare Part D; Medication Therapy Management; Medicare Part B; reimbursement for pharmacist services; Social Security Act; DME; CMMI; transitions of care; risk evaluation and mitigation services; prescription drug monitoring program; prescription drug abuse; hydrocodone; opiods; track and trace/supply chain; ACOs; immunization; HIT; compounding; Sustainable Growth Rate; FDASIA(PL 112-144); tele-medicine; Medicare fraud, waste and abuse
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2013 · second_quarter · Q2
HCR(PL 111-152/111-148); Medicare Part D; MTM; Medicare Part B; pharmacy reimbursement; DME; CMMI; transitions of care; risk evaluation and mitigation services; prescription drug monitoring program; prescription drug abuse; hydrocodone; track and trace/supply chain; ACOs; immunization; HIT; compounding; SGR; DEA; PDUFA
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2013 · first_quarter · Q1
HCR(PL 111-152/111-148) concerning Medicare PartD;MTM;DME;center for medicare and medicaid innovation;transitions of care;pharmacy reibursement;agency issues concerning risk evaluation mitigation strategies;PDUFA;prescription drug monitoring program,drug abuse,safe drug supply chain;standardized medication action plans;ACOs;pharmacists role in CMS innovation center initiatives;personalized medication lists; standardized pharmacy notice;immunization;HIT; compounding; medicare Part B; SGR; DEA
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2012 · third_quarter · 3A
HCR(PL 111-152/111-148); Medicare Part D; Medication Therapy Management; Medicare Part B; reimbursement for pharmacist services; Social Security Act; transitions of care; risk evaluation and mitigation services; prescription drug monitoring program; prescription drug abuse; hydrocodone; track and trace/supply chain; ACOs; immunization; HIT; compounding; Sustainable Growth Rate; FDASIA(PL 112-144); tele-medicine; Medicare fraud, waste and abuse; quality rating; AMP FUL's
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2012 · fourth_quarter · 4A
HCR(PL 111-152/111-148); Medicare Part D; Medication Therapy Management; Medicare Part B; reimbursement for pharmacist services; Social Security Act; DME; CMMI; transitions of care; risk evaluation and mitigation services; prescription drug monitoring program; prescription drug abuse; hydrocodone; track and trace/supply chain; ACOs; immunization; HIT; compounding; Sustainable Growth Rate; FDASIA(PL 112-144); tele-medicine; Medicare fraud, waste and abuse; quality rating; standardized pharmacy notice
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2012 · fourth_quarter · Q4
HCR(PL 111-152/111-148) concerning Medicare PartD;MTM;DME;transitions of care;pharmacy reibursement; agency issues concerning risk evaluation mitigation strategies;prescription drug monitoring program,drug abuse,safe drug supply chain;standardized medication action plans;personalized medication lists;ACOs;pharmacists role in CMS Innovation Center initiatives;immunization;HIT; medication disposal;biosmiliars;EHB; compounding;SGR
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2012 · third_quarter · Q3
HCR(PL 111-152/111-148) concerning Medicare PartD;MTM;DME;center for medicare and medicaid innovation;transitions of care;pharmacy reimbursement;agency issues concerning risk evaluation mitigation strategies;PDUFA;prescription drug monitoring program,drug abuse,safe drug supply chain;standardized medication action plans;ACOs;pharmacists role in CMS innovation center initiatives;personalized medication lists; standardized pharmacy notice;immunization;HIT; compounding;medicare part B;SGR;DEA
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2012 · second_quarter · Q2
HCR(PL 111-152/111-148) concerning Medicare PartD;MTM;DME;transitions of care;pharmacy reibursement; loan forgiveness;agency issues concerning risk evaluation mitigation strategies;PDUFA;prescription drug monitoring program,drug abuse,safe drug supply chain;standardized medication action plans;personalized medication lists;ACOs;pharmacists role in CMS Innovation Center initiatives;standardized pharmacy notice;immunization;HIT; medication disposal;biosmiliars;EHB
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2012 · first_quarter · Q1
Legislative and agency issues regarding the Patient Protection and Affordable Care Act (P.L. 111-148) - Appropriations for the medication therapy management grant program.
S. 274 Medication Therapy Management Empowerment Act of 2011. H.R. 891 Medication Therapy Management Benefits Act of 2011. Agency issues related to standardized medication action plans; accountable care organizations (ACOs); pharmacists' participation in CMS Innovation Center initiatives; coverage for outpatient drugs; transparency and reporting of physician investment interests (Sunshine Act); potential new paradigm for drugs; essential health benefits (EHB); and standardized pharmacy notice.
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2011 · fourth_quarter · Q4
Legislative and agency issues regarding the Health Care and Education Reconciliation Act of 2010 (P.L. 111-152) and the Patient Protection and Affordable Care Act (P.L. 111-148) including sections concerning Medicare Part D changes; medication therapy management (MTM); accountable care organizations (ACOs); durable medical equipment (DME); Center for Medicare and Medicaid Innovation within CMS; transitions of care; essential health benefits; and providing adequate pharmacy reimbursement (AMP).
S. 2.74 Medication Therapy Management Empowerment Act of 2011. H.R. 891 Medication Therapy management Benefits Act of 2011. Agency issues related to standardized medication action plans; accountable care organizations; pharmacists' participation in the CMS Innovation Center initiatives; personalized medication lists; essential health benefits; and standardized pharmacy notice.
AMERICAN PHARMACISTS ASSOCIATION via AMERICAN PHARMACISTS ASSOCIATION
2011 · third_quarter · Q3
S.48 Pharmacist Loan Repayment Eligibility Act of 2011 Agency issues relating to risk evaluation and mitigation strategies (REMS); the Prescription Drug User Fee Act (PDUFA); prescription drug monitoring programs; prescription drug abuse; and safety of the drug supply chain.
Legislative and agency issues regarding the Patient Protection and Affordable Care Act (P.L. 111-148) - Appropriations for the medication therapy management grant program. Communications with the Joint Committee on Deficit Reduction on maintaining funding for Medicare Part D provisions such as medication therapy management programs and preserving patient access to pharmacist provided care services.
Prescription drug monitoring programs Prescription drug abuse Prescription drug disposal
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
Medicare Part D Medication Therapy Management Medicare Part B Medicare waste, fraud and abuse Value-based payements
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
Legislative and agency issues regarding drug shortages, the reauthorization of the Prescription Drug User Fee Act (PDUFA), drug counterfeiting, supply chain integrity, drug diversion and controlled substance monitoring. Also, the Health Care and Education Reconciliation Act of 2010 (P.L. 111-145) and the Patient Protection and Affordability Act (P.L. 111-148) including sections concerning Medicare Part D changes; medication therapy management (MTM); accountable care organizations (ACOs); durable medical equipment (DME); Center for Medicare and Medicaid Innovation within CMS; transitions of care; essential health benefits (EHB); and providing adequate pharmacy reimbursement (AMP).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Legislative and agency issues regarding the Patient Protection and Affordable Care Act (P.L. 111-148) - Appropriations for the medication therapy management grant program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Legislative and agency issues regarding the Health Care and Education Reconciliation Act of 2010 (P.L. 111-152) and the Patient Protection and Affordable Care Act (P.L. 111-148) including sections concerning Medicare Part D changes; medication therapy management (MTM); accountable care organizations (ACOs); durable medical equipment (DME); Center for Medicare and Medicaid Innovation within CMS; transitions of care; and providing adequate pharmacy reimbursement (AMP).
S.274 Medication Therapy Management Empowerment Act of 2011 H.R.891 Medication Therapy Management Benefits Act of 2011 Agency issues related to standardized medication action plans; accountable care organizations; pharmacists' participation in the CMS Innovation Center initiatives; personalized medication lists; standardized pharmacy notice. immunization; and health information technology. Communications with the Joint Select Committee on Deficit Reduction on preserving patient access to medication therapy management services in Medicare Part D, fair reimbursement in Medicare and Medicaid.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE